SelectIQ
SelectIQ, based in New York, NY, leverages technology to streamline the recruitment of patients for clinical trials by analyzing electronic health records (EHR) to match patients with appropriate trials, aiming to bridge the gap between doctors' intentions and actions in informing patients about clinical trials.
Company History and Evolution
SelectIQ, formerly known as Recomp, Resync, and Workpage, operates out of New York, NY, USA. The company has evolved through various iterations, reflecting an ongoing commitment to innovation in the healthcare industry. With a small but dedicated team of two professionals, SelectIQ focuses on addressing significant challenges in the clinical trial recruitment process.
Services Provided by SelectIQ
SelectIQ offers a Provider Activation Platform designed to streamline the clinical trial recruitment process. This platform reduces the burden on trial sites and the providers who send participants by making it easy to identify eligible patients. Key features include automatic patient pre-screening based on Electronic Health Records (EHR), accurate enrollment predictions, and integration of trial information into providers’ daily workflows through a daily printout. This ensures that trials remain top of mind for providers and simplifies patient education.
Industry Focus and Mission
Operating in the healthcare sector, specifically within the B2B engineering, product, and design sub-industry, SelectIQ targets the critical bottleneck in drug development: patient recruitment for clinical trials. The company's mission is to bridge the gap between doctors' desire to inform patients about clinical trials and their actual ability to do so. SelectIQ aims to bring safer, more effective drugs to patients by optimizing the recruitment process.
Regions and Operational Scope
SelectIQ serves regions including the United States of America, America/Canada, and offers both remote and partly remote operations. This flexibility allows the company to effectively cater to a diverse range of healthcare providers and trial sites, enhancing their capacity to efficiently match patients with relevant clinical trials.
Y-Combinator Batch and Support
SelectIQ is a part of the Y Combinator Winter 2023 (W23) batch. This affiliation with a prestigious accelerator highlights the company's innovative approach and provides them with valuable resources and support to scale their solutions in the healthcare industry.
